Head-to-head comparisons of medication uses, side effects, warnings, and more.
Opdivo (nivolumab)
Opdivo qvantig
Opdivo (nivolumab)
Opdivo qvantig
Summary of Opdivo vs. Opdivo Qvantig
Summary for PD-1 inhibitor
Prescription only
Opdivo (nivolumab) is a type of immunotherapy medication used to treat many types of cancer. They can include melanoma, lung cancer, kidney cancer, colon cancer, and others. Opdivo (nivolumab) is given as infusion through the vein (IV) every few weeks at an infusion center. This medication can cause side effects, like rash, diarrhea, and breathing problems. Depending on the cancer treated, Opdivo (nivolumab) can be used by itself or with other therapies.
Summary for PD-1 inhibitor
Prescription only
Opdivo Qvantig (nivolumab / hyaluronidase) is an injection that’s given under the skin. It’s an immunotherapy medication approved to treat adults with certain cancers, like melanoma and kidney cancer. A healthcare professional will help inject it into your stomach or thigh at a clinic every few weeks. Opdivo Qvantig can cause side effects like rash, trouble breathing, and diarrhea. It can also cause injection site reactions like redness or swelling. Depending on the type of cancer you have, it might be used alone or with other treatments.